Overexpression of Apolipoprotein A1 in the Lung Abrogates Fibrosis in Experimental Silicosis

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Lee, Eun hee ^a   Lee, Eun ju ^a   Kim, Hee jeong ^a   Jang, An soo ^a   Koh, Eun suk ^a   Uh, Soo taek ^a   Kim, Yong hoon ^a   Park, Sung woo ^a   Park, Choon sik ^a  

^a Soonchunhyang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; COLLAGEN; LIPOXIN A; SILICON DIOXIDE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL COUNT; CONTROLLED STUDY; DRUG EFFICACY; GENE OVEREXPRESSION; HISTOPATHOLOGY; LUNG ALVEOLUS EPITHELIUM; LUNG LAVAGE; LUNG NODULE; MALE; MOUSE; NONHUMAN; SILICOSIS;

ANIMALS; APOLIPOPROTEIN A-I; APOPTOSIS; COLLAGEN; DISEASE MODELS, ANIMAL; DOXYCYCLINE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MICE; MICE, TRANSGENIC; PULMONARY FIBROSIS; SILICON DIOXIDE; SILICOSIS; SOLITARY PULMONARY NODULE; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84873627511     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055827     Document Type: Article

References (41)

1. Navab M, Anantharamaiah GM, Reddy ST, Hama S, Hough G, et al. (2005) Oral small peptides render HDL antiinflammatory in mice and monkeys and reduce atherosclerosis in ApoE null mice. Circ Res 97: 524-532.
2. Reddy ST, Anantharamaiah GM, Navab M, Hama S, Hough G, et al. (2006) Oral amphipathic peptides as therapeutic agents. Expert Opin Investig Drugs 15: 13-21.
3. Van Lenten BJ, Navab M, Anantharamaiah GM, Buga GM, Reddy ST, et al. (2008) Multiple indications for anti-inflammatory apolipoprotein mimetic peptides. Curr Opin Investig Drugs 9: 1157-1162.
4. Nandedkar SD, Weihrauch D, Xu H, Shi Y, Feroah T, et al. (2011) D-4F, an apoA-1 mimetic, decreases airway hyperresponsiveness, inflammation, and oxidative stress in a murine model of asthma. J Lipid Res 52: 499-508.
5. Kim TH, Lee YH, Kim KH, Lee SH, Cha JY, et al. (2010) Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis. Am J Respir Crit Care Med 182: 633-642.
6. Phan SH, Armstrong G, Sulavik MC, Schrier D, Johnson KJ, et al. (1983) A comparative study of pulmonary fibrosis induced by bleomycin and an O2 metabolite producing enzyme system. Chest 83: 44S-45S.
7. Gharaee-Kermani M, Hatano K, Nozaki Y, Phan SH, (2005) Gender-based differences in bleomycin-induced pulmonary fibrosis. Am J Pathol 166: 1593-1606.
8. Lawson WE, Polosukhin VV, Stathopoulos GT, Zoia O, Han W, et al. (2005) Increased and prolonged pulmonary fibrosis in surfactant protein C-deficient mice following intratracheal bleomycin. Am J Pathol 167: 1267-1277.
9. Lo Re S, Dumoutier L, Couillin I, Van Vyve C, Yakoub Y, et al. (2010) IL-17A-producing gammadelta T and Th17 lymphocytes mediate lung inflammation but not fibrosis in experimental silicosis. J Immunol 184: 6367-6377.
10. Sato T, Shimosato T, Alvord WG, Klinman DM, (2008) Suppressive oligodeoxynucleotides inhibit silica-induced pulmonary inflammation. J Immunol 180: 7648-7654.
11. Mossman BT, Churg A, (1998) Mechanisms in the pathogenesis of asbestosis and silicosis. Am J Respir Crit Care Med 157: 1666-1680.
12. Hnizdo E, Vallyathan V, (2003) Chronic obstructive pulmonary disease due to occupational exposure to silica dust: a review of epidemiological and pathological evidence. Occup Environ Med 60: 237-243.
13. Park SW LE, Lee EJ, Park CS (2011) ApolipoproteinA1 Promote Resolution Of Lung Inflammation And Fibrosis In Experimental Silicosis [abstract]. Presented at international conference of American thoracic society, ATS. Denver, USA.
14. Park SW, Verhaeghe C, Nguyenvu LT, Barbeau R, Eisley CJ, et al. (2009) Distinct roles of FOXA2 and FOXA3 in allergic airway disease and asthma. Am J Respir Crit Care Med 180: 603-610.
15. Chomczynski P, Sacchi N, (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159.
16. Weibel ER (1990) Morphometry: stereological theory and practical methods. In: J Gil, editor. Models of Lung DiseaseMicroscopy and Structural Methods, Vol. 47. Marcel Dekker, New York. pp199-247.
17. Lassance RM, Prota LF, Maron-Gutierrez T, Garcia CS, Abreu SC, et al. (2009) Intratracheal instillation of bone marrow-derived cell in an experimental model of silicosis. Respir Physiol Neurobiol 169: 227-233.
18. Tsuchiya K, Inase N, Ichinose S, Usui Y, Miyazaki Y, et al. (2007) Elemental analysis of inorganic dusts in lung tissues of interstitial pneumonias. J Med Dent Sci 54: 9-16.
19. Kuwano K, Hagimoto N, Kawasaki M, Yatomi T, Nakamura N, et al. (1999) Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis. J Clin Invest 104: 13-19.
20. Blake TL, DiMatteo M, Antonini JM, McCloud CM, Reasor MJ, (1996) Subchronic pulmonary inflammation and fibrosis induced by silica in rats are attenuated by amiodarone. Exp Lung Res 22: 113-131.
21. Fujita M, Ye Q, Ouchi H, Harada E, Inoshima I, et al. (2006) Doxycycline attenuated pulmonary fibrosis induced by bleomycin in mice. Antimicrob Agents Chemother 50: 739-743.
22. Iyer R, Hamilton RF, Li L, Holian A, (1996) Silica-induced apoptosis mediated via scavenger receptor in human alveolar macrophages. Toxicol Appl Pharmacol 141: 84-92.
23. Wang L, Bowman L, Lu Y, Rojanasakul Y, Mercer RR, et al. (2005) Essential role of p53 in silica-induced apoptosis. Am J Physiol Lung Cell Mol Physiol 288: L488-496.
24. Huaux F, Louahed J, Hudspith B, Meredith C, Delos M, et al. (1998) Role of interleukin-10 in the lung response to silica in mice. Am J Respir Cell Mol Biol 18: 51-59.
25. Faffe DS, Silva GH, Kurtz PM, Negri EM, Capelozzi VL, et al. (2001) Lung tissue mechanics and extracellular matrix composition in a murine model of silicosis. J Appl Physiol 90: 1400-1406.
26. Lardot CG, Huaux FA, Broeckaert FR, Declerck PJ, Delos M, et al. (1998) Role of urokinase in the fibrogenic response of the lung to mineral particles. Am J Respir Crit Care Med 157: 617-628.
27. Ortiz LA, Lasky J, Gozal E, Ruiz V, Lungarella G, et al. (2001) Tumor necrosis factor receptor deficiency alters matrix metalloproteinase 13/tissue inhibitor of metalloproteinase 1 expression in murine silicosis. Am J Respir Crit Care Med 163: 244-252.
28. Maron-Gutierrez T, Castiglione RC, Xisto DG, Oliveira MG, Cruz FF, et al. (2011) Bone marrow-derived mononuclear cell therapy attenuates silica-induced lung fibrosis. Eur Respir J.
29. Borges VM, Falcao H, Leite-Junior JH, Alvim L, Teixeira GP, et al. (2001) Fas ligand triggers pulmonary silicosis. J Exp Med 194: 155-164.
30. Jagirdar J, Begin R, Dufresne A, Goswami S, Lee TC, et al. (1996) Transforming growth factor-beta (TGF-beta) in silicosis. Am J Respir Crit Care Med 154: 1076-1081.
31. Barrett EG, Johnston C, Oberdorster G, Finkelstein JN, (1999) Silica binds serum proteins resulting in a shift of the dose-response for silica-induced chemokine expression in an alveolar type II cell line. Toxicol Appl Pharmacol 161: 111-122.
32. Serhan CN, Chiang N, Van Dyke TE, (2008) Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8: 349-361.
33. Levy BD, (2005) Lipoxins and lipoxin analogs in asthma. Prostaglandins Leukot Essent Fatty Acids 73: 231-237.
34. Bonnans C, Chanez P, Chavis C, (2004) Lipoxins in asthma: potential therapeutic mediators on bronchial inflammation? Allergy 59: 1027-1041.
35. Gewirtz AT, McCormick B, Neish AS, Petasis NA, Gronert K, et al. (1998) Pathogen-induced chemokine secretion from model intestinal epithelium is inhibited by lipoxin A4 analogs. J Clin Invest 101: 1860-1869.
36. Hachicha M, Pouliot M, Petasis NA, Serhan CN, (1999) Lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor 1alpha-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis. J Exp Med 189: 1923-1930.
37. Papayianni A, Serhan CN, Brady HR, (1996) Lipoxin A4 and B4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells. J Immunol 156: 2264-2272.
38. Godson C, Mitchell S, Harvey K, Petasis NA, Hogg N, et al. (2000) Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J Immunol 164: 1663-1667.
39. Mitchell S, Thomas G, Harvey K, Cottell D, Reville K, et al. (2002) Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo. J Am Soc Nephrol 13: 2497-2507.
40. Haworth O, Cernadas M, Yang R, Serhan CN, Levy BD, (2008) Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation. Nat Immunol 9: 873-879.
41. Borgeson E, Docherty NG, Murphy M, Rodgers K, Ryan A, et al. (2011) Lipoxin A4 and benzo-lipoxin A4 attenuate experimental renal fibrosis. FASEB J 25: 2967-2979.